214 related articles for article (PubMed ID: 22732506)
1. Co-regulation of survival of motor neuron and Bcl-xL expression: implications for neuroprotection in spinal muscular atrophy.
Anderton RS; Price LL; Turner BJ; Meloni BP; Mitrpant C; Mastaglia FL; Goh C; Wilton SD; Boulos S
Neuroscience; 2012 Sep; 220():228-36. PubMed ID: 22732506
[TBL] [Abstract][Full Text] [Related]
2. A new model to study spinal muscular atrophy: neurite degeneration and cell death is counteracted by BCL-X(L) Overexpression in motoneurons.
Garcera A; Mincheva S; Gou-Fabregas M; Caraballo-Miralles V; Lladó J; Comella JX; Soler RM
Neurobiol Dis; 2011 Jun; 42(3):415-26. PubMed ID: 21333739
[TBL] [Abstract][Full Text] [Related]
3. Restoring Bcl-x(L) levels benefits a mouse model of spinal muscular atrophy.
Tsai LK; Tsai MS; Ting CH; Wang SH; Li H
Neurobiol Dis; 2008 Sep; 31(3):361-7. PubMed ID: 18590823
[TBL] [Abstract][Full Text] [Related]
4. Survival of motor neuron protein over-expression prevents calpain-mediated cleavage and activation of procaspase-3 in differentiated human SH-SY5Y cells.
Anderton RS; Meloni BP; Mastaglia FL; Greene WK; Boulos S
Neuroscience; 2011 May; 181():226-33. PubMed ID: 21333717
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells.
Grzeschik SM; Ganta M; Prior TW; Heavlin WD; Wang CH
Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920
[TBL] [Abstract][Full Text] [Related]
6. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
Liu H; Shafey D; Moores JN; Kothary R
J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
[TBL] [Abstract][Full Text] [Related]
7. A role for complexes of survival of motor neurons (SMN) protein with gemins and profilin in neurite-like cytoplasmic extensions of cultured nerve cells.
Sharma A; Lambrechts A; Hao le T; Le TT; Sewry CA; Ampe C; Burghes AH; Morris GE
Exp Cell Res; 2005 Sep; 309(1):185-97. PubMed ID: 15975577
[TBL] [Abstract][Full Text] [Related]
8. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy.
Iwahashi H; Eguchi Y; Yasuhara N; Hanafusa T; Matsuzawa Y; Tsujimoto Y
Nature; 1997 Nov; 390(6658):413-7. PubMed ID: 9389483
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit.
Anderson KN; Baban D; Oliver PL; Potter A; Davies KE
Neuromuscul Disord; 2004 Nov; 14(11):711-22. PubMed ID: 15482955
[TBL] [Abstract][Full Text] [Related]
11. Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy.
Jarecki J; Chen X; Bernardino A; Coovert DD; Whitney M; Burghes A; Stack J; Pollok BA
Hum Mol Genet; 2005 Jul; 14(14):2003-18. PubMed ID: 15944201
[TBL] [Abstract][Full Text] [Related]
12. The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy.
Wan L; Battle DJ; Yong J; Gubitz AK; Kolb SJ; Wang J; Dreyfuss G
Mol Cell Biol; 2005 Jul; 25(13):5543-51. PubMed ID: 15964810
[TBL] [Abstract][Full Text] [Related]
13. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy.
Vezain M; Saugier-Veber P; Melki J; Toutain A; Bieth E; Husson M; Pedespan JM; Viollet L; Pénisson-Besnier I; Fehrenbach S; Bou J; Frébourg T; Tosi M
Eur J Hum Genet; 2007 Oct; 15(10):1054-62. PubMed ID: 17609673
[TBL] [Abstract][Full Text] [Related]
14. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells.
Angelozzi C; Borgo F; Tiziano FD; Martella A; Neri G; Brahe C
J Med Genet; 2008 Jan; 45(1):29-31. PubMed ID: 17932121
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.
Brichta L; Hofmann Y; Hahnen E; Siebzehnrubl FA; Raschke H; Blumcke I; Eyupoglu IY; Wirth B
Hum Mol Genet; 2003 Oct; 12(19):2481-9. PubMed ID: 12915451
[TBL] [Abstract][Full Text] [Related]
16. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer.
Chen ZY; Cai L; Zhu J; Chen M; Chen J; Li ZH; Liu XD; Wang SG; Bie P; Jiang P; Dong JH; Li XW
Carcinogenesis; 2011 Oct; 32(10):1419-26. PubMed ID: 21642356
[TBL] [Abstract][Full Text] [Related]
17. p38 Mitogen-activated protein kinase stabilizes SMN mRNA through RNA binding protein HuR.
Farooq F; Balabanian S; Liu X; Holcik M; MacKenzie A
Hum Mol Genet; 2009 Nov; 18(21):4035-45. PubMed ID: 19648294
[TBL] [Abstract][Full Text] [Related]
18. Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy.
Liu H; Beauvais A; Baker AN; Tsilfidis C; Kothary R
Dev Neurobiol; 2011 Feb; 71(2):153-69. PubMed ID: 20862739
[TBL] [Abstract][Full Text] [Related]
19. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ
Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471
[TBL] [Abstract][Full Text] [Related]
20. Splicing changes in SMA mouse motoneurons and SMN-depleted neuroblastoma cells: evidence for involvement of splicing regulatory proteins.
Huo Q; Kayikci M; Odermatt P; Meyer K; Michels O; Saxena S; Ule J; Schümperli D
RNA Biol; 2014; 11(11):1430-46. PubMed ID: 25692239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
